{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:25:52Z","timestamp":1793258752213,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacadv.2026.103207","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:17:28Z","timestamp":1788481048000},"page":"103207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Cholesterol Management Gaps Among Patients With Established Coronary Artery Disease Hospitalized for Acute Coronary Events"],"prefix":"10.1016","volume":"5","author":[{"given":"Lisandro D.","family":"Colantonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B.","family":"Levitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.103207_bib1","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib2","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2023-000107","article-title":"Myocardial infarction and physical function: the REasons for geographic and racial differences in stroke prospective cohort study","volume":"1","author":"Levitan","year":"2023","journal-title":"BMJ Public Health"},{"key":"10.1016\/j.jacadv.2026.103207_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011322","article-title":"Acute and 1-Year hospitalization costs for acute myocardial infarction treated with percutaneous coronary intervention: results from the TRANSLATE-ACS registry","volume":"8","author":"Cowper","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2026.103207_bib5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ahj.2010.08.041","article-title":"Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG)","volume":"160","author":"Javed","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacadv.2026.103207_bib6","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.jacc.2022.02.049","article-title":"Trends in high-intensity statin therapy after myocardial infarction among U.S. adults, 2011-2019","volume":"79","author":"Colantonio","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.2023.8646","article-title":"Low-density lipoprotein cholesterol levels in adults with coronary artery disease in the US, January 2015 to march 2020","volume":"330","author":"Aggarwal","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2026.103207_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/HPC.0b013e31812da7ed","article-title":"Improved treatment of hospitalized coronary artery disease patients with the get with the guidelines program","volume":"6","author":"LaBresh","year":"2007","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jamacardio.2019.2481","article-title":"Association of region and hospital and patient characteristics with use of high-intensity statins after myocardial infarction among medicare beneficiaries","volume":"4","author":"Bittner","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2018.02.032","article-title":"Sex differences in high-intensity statin use following myocardial infarction in the United States","volume":"71","author":"Peters","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010376","article-title":"Adherence to statin therapy among US adults between 2007 and 2014","volume":"8","author":"Colantonio","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2026.103207_bib12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7326\/M23-0720","article-title":"Disparities in guideline-recommended statin use for prevention of atherosclerotic cardiovascular disease by race, ethnicity, and gender: a nationally representative cross-sectional analysis of adults in the United States","volume":"176","author":"Frank","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacadv.2026.103207_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jamacardio.2023.0228","article-title":"Prevalence of statin use for primary prevention of atherosclerotic cardiovascular disease by race, ethnicity, and 10-Year disease risk in the US: National health and nutrition examination surveys, 2013 to march 2020","volume":"8","author":"Jacobs","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib14","first-page":"259","article-title":"KDIGO clinical practice guideline for lipid management in chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jacadv.2026.103207_bib15","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacc.2015.02.003","article-title":"2015 ACC\/AHA focused update of secondary prevention lipid performance measures: a report of the American College of Cardiology\/American Heart Association task force on performance measures","volume":"67","author":"Drozda","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib17","article-title":"The importance of low-density lipoprotein cholesterol measurement and control as performance measures: a joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology","volume":"13","author":"Virani","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1590\/S0034-89102008000600003","article-title":"Methods for estimating prevalence ratios in cross-sectional studies","volume":"42","author":"Coutinho","year":"2008","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.jacadv.2026.103207_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jacl.2021.08.001","article-title":"Race\/Ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction","volume":"15","author":"Colvin","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacadv.2026.103207_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.124.010967","article-title":"Empowering research with the American Heart Association get with the guidelines registries through integration of a database and research tools","volume":"17","author":"Beon","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacadv.2026.103207_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jacc.2026.03.157","article-title":"Secondary prevention after myocardial infarction in the United States","volume":"88","author":"Chiu","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2019.11.011","article-title":"Trends in U.S. Ambulatory Cardiovascular Care 2013 to 2017: JACC review topic of the week","volume":"75","author":"Maddox","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ahj.2024.06.012","article-title":"Achievement of LDL-C <55 mg\/dL among US adults: findings from the cvMOBIUS2 registry","volume":"279","author":"Navar","year":"2025","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacadv.2026.103207_bib24","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2026.103207_bib25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib26","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103207_bib27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10557-023-07452-1","article-title":"Recurrent atherosclerotic cardiovascular disease events potentially prevented with guideline-recommended cholesterol-lowering therapy following myocardial infarction","volume":"38","author":"Sakhuja","year":"2024","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacadv.2026.103207_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ahj.2017.08.005","article-title":"Lipid management in contemporary community practice: results from the Provider Assessment of Lipid Management (PALM) registry","volume":"193","author":"Navar","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacadv.2026.103207_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008861","article-title":"Lipid-lowering therapy use and intensification among United States veterans following myocardial infarction or coronary revascularization between 2015 and 2019","volume":"15","author":"Zheutlin","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacadv.2026.103207_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103270","article-title":"Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysis","volume":"84","author":"Yow","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacadv.2026.103207_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100753","article-title":"Low-density lipoprotein cholesterol testing following myocardial infarction hospitalization among medicare beneficiaries","volume":"3","author":"Colantonio","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacadv.2026.103207_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.124.011627","article-title":"American heart Association national integrated ASCVD initiative: an implementation initiative to improve lipid management among patients with ASCVD","volume":"18","author":"Ndumele","year":"2025","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacadv.2026.103207_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.amjcard.2018.05.016","article-title":"Willingness to be reinitiated on a statin (from the REasons for geographic and racial differences in stroke study)","volume":"122","author":"Mefford","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/CIRCULATIONAHA.116.025848","article-title":"Black-white differences in incident fatal, nonfatal, and total coronary heart disease","volume":"136","author":"Colantonio","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103207_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ije\/dyp334","article-title":"Illustrating bias due to conditioning on a collider","volume":"39","author":"Cole","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacadv.2026.103207_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10557-013-6497-2","article-title":"Patient co-payment and adherence to statins: a review and case studies","volume":"28","author":"Simoens","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacadv.2026.103207_bib37","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","article-title":"Full coverage for preventive medications after myocardial infarction","volume":"365","author":"Choudhry","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103207_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.eprac.2024.09.016","article-title":"American Association of Clinical Endocrinology Clinical Practice guideline on pharmacologic management of adults with dyslipidemia","volume":"31","author":"Patel","year":"2025","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacadv.2026.103207_bib39","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.3399\/bjgp18X696173","article-title":"Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care","volume":"68","author":"Kr\u00fcger","year":"2018","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jacadv.2026.103207_bib40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11883-024-01224-4","article-title":"Cholesterol lowering in older adults: should we wait for further evidence?","volume":"26","author":"Jamil","year":"2024","journal-title":"Curr Atheroscler Rep"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26006289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26006289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:24:40Z","timestamp":1793215480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26006289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2772963X26006289"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103207","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol Management Gaps Among Patients With Established Coronary Artery Disease Hospitalized for Acute Coronary Events","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103207"}}